Home/Pipeline/TPN171 (Simenafil hydrochloride) Tablets

TPN171 (Simenafil hydrochloride) Tablets

Erectile Dysfunction

ApprovedMarketed in China and Uzbekistan

Key Facts

Indication

Erectile Dysfunction

Phase

Approved

Status

Marketed in China and Uzbekistan

Company

Vigonvita

About Vigonvita

A Chinese biopharma company with a fully integrated platform developing and commercializing drugs for viral infections, neuropsychiatry, and reproductive health.

View full company profile

Therapeutic Areas

Infectious Disease Neurology Psychiatry Urology/Reproductive Health

Other Erectile Dysfunction Drugs

Drug	Company	Phase	Status
CF602	Can Fite Biopharma	Preclinical	Active
E300 ESWT System	Wikkon	Commercial	Market Released
Sildenafil Citrate	Azico Biophore	Commercial	Active
Sildenafil Formulation	InnovaZone Labs	Approved	Active
Rigi10™ Malleable Penile Prosthesis	Rigicon	Approved	Commercial
UNITED Study (Investigational Inflatable Penile Prosthesis)	Rigicon	Clinical Investigation	Active
ASP-001	Aspargo Laboratories	Approved	Active
Sildenafil-loaded Z-pods®	Atticus Pharma	Pre-clinical	Active
FGF-based Therapeutic	Venturis Therapeutics	Pre-clinical	Active
DehydraTECH-sildenafil	Lexaria Bioscience	Human Clinical	Active